首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 2,2'-((3S,6R,11R,14S,20S,23S,31aS)-11-氨基-23-(4-氨基丁基)-6-羧基-14-(3-((二氨基亚甲基)氨基)丙基)-1,4,12,15,18,21,24,27-八氧代二十八氢-1H-吡咯并[2,1-j][1,2]二硫杂[5,8,11,14,17,20,23,26]八氮杂环二十九碳-3,20-二基)二乙酸

2,2'-((3S,6R,11R,14S,20S,23S,31aS)-11-氨基-23-(4-氨基丁基)-6-羧基-14-(3-((二氨基亚甲基)氨基)丙基)-1,4,12,15,18,21,24,27-八氧代二十八氢-1H-吡咯并[2,1-j][1,2]二硫杂[5,8,11,14,17,20,23,26]八氮杂环二十九碳-3,20-二基)二乙酸

2,2'-((3S,6R,11R,14S,20S,23S,31aS)-11-amino-23-(4-aminobutyl)-6-carboxy-14-(3-((diaminomethylene)amino)propyl)-1,4,12,15,18,21,24,27-octaoxooctacosahydro-1H-pyrrolo[2,1-j][1,2]dithia[5,8,11,14,17,20,23,26]octaazacyclononacosine-3,20-diyl)diacetic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1392278-76-0

中文名称

2,2'-((3S,6R,11R,14S,20S,23S,31aS)-11-氨基-23-(4-氨基丁基)-6-羧基-14-(3-((二氨基亚甲基)氨基)丙基)-1,4,12,15,18,21,24,27-八氧代二十八氢-1H-吡咯并[2,1-j][1,2]二硫杂[5,8,11,14,17,20,23,26]八氮杂环二十九碳-3,20-二基)二乙酸

英文名称

2,2'-((3S,6R,11R,14S,20S,23S,31aS)-11-amino-23-(4-aminobutyl)-6-carboxy-14-(3-((diaminomethylene)amino)propyl)-1,4,12,15,18,21,24,27-octaoxooctacosahydro-1H-pyrrolo[2,1-j][1,2]dithia[5,8,11,14,17,20,23,26]octaazacyclononacosine-3,20-diyl)diacetic acid

别名

L-Cysteine, L-cysteinyl-L-arginylglycyl-L-alpha-aspartyl-L-lysylglycyl-L-prolyl-L-alpha-aspartyl-, cyclic (1->9)-disulfide | (6S,9S,15S,18R,23R,26S,29S)-18-amino-6-(4-aminobutyl)-9,26-bis(carboxymethyl)-15-[3-(diaminomethylideneamino)propyl]-2,5,8,11,14,1

标准英文名

2,2'-((3S,6R,11R,14S,20S,23S,31aS)-11-amino-23-(4-aminobutyl)-6-carboxy-14-(3-((diaminomethylene)amino)propyl)-1,4,12,15,18,21,24,27-octaoxooctacosahydro-1H-pyrrolo[2,1-j][1,2]dithia[5,8,11,14,17,20,23,26]octaazacyclononacosine-3,20-diyl)diacetic acid

分子式

C35H57N13O14S2

分子量

948.05

精确分子量

947.36

SMILES

NCCCC[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)CNC1=O

标准SMILES

NC(N)=NCCC[C@@H]1NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(O)=O

用途

iRGD peptide enhances tumor targeting and tissue penetration of therapeutics by first binding to αv-integrins and then undergoing proteolytic cleavage to expose a C-end rule (CendR) motif (CRGDK/R) that interacts with neuropilin-1 (NRP-1), promoting cellular internalization; it enhances the chemotherapeutic efficacy of 5-fluorouracil (5-FU) in gastric cancer cells via NRP1; when incorporated into oncolytic adenovirus ICOVIR15K, it improves early viral dissemination within tumor masses and augments antitumor effects in vivo; co-administration of iRGD peptide with 5-FU significantly suppresses tumor growth in nude mice bearing human gastric cancer cells.

InChIKey

YHTTWXCDIRTOQX-FQJIPJFPSA-N

安全信息

SureRoute逆合成路线

1.  1392278-76-0 逆合成路线 1

—
—
ACZYCV213
1392278-76-0
来源: SureRoute

2.  1392278-76-0 逆合成路线 2

—
—
ACZYCV213
1392278-76-0
来源: SureRoute

3.  1392278-76-0 逆合成路线 3

—
—
ACZYCV213
1392278-76-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手